Carma Laboratories' NEW Carmex Cold Sore Treatment named 2015 'Product of the Year' winner

NewsGuard 100/100 Score

Carma Laboratories, Inc., the manufacturer of Carmex® lip balm products, is pleased to announce that its NEW Carmex® Cold Sore Treatment has been named the 2015 "Product of the Year" winner in the Specialty Skin Treatment category by Product of the Year USA – the nation's largest consumer survey on product innovation.

The "Product of the Year" award is backed by the votes of over 40,000 consumers, serving as a shortcut for shoppers in the supermarket. For manufacturers of the winning products, the award is a powerful marketing tool that has shown to increase product trial, awareness, distribution and sales. Over the past 25 years, winners across the globe have reported an average sales increase of 10-15%. Furthermore, leading global research company TNS recently conducted a study with US shoppers and found that:

  • "Product of the Year" USA winners outperform category sales performance by 38.1%
  • The "Product of the Year" logo is more effective on a package than the word "NEW"
  • Coupon redemption consideration increased 24% when the "Product of the Year" logo is featured in an FSI

Only NEW Carmex® Cold Sore Treatment works on contact to block pain and itch while minimizing the appearance of a cold sore. 10% Benzocaine blocks pain and itch, while the TriPLEX™ Formula technology smoothes and fills to make the cold sore less noticeable. And, it works on contact – so you see and feel results fast. While no product can cure a cold sore, this breakthrough product may help sufferers feel more comfortable and confident while managing through a cold sore outbreak.

"We are honored that Carmex Cold Sore Treatment was voted as winner in the Specialty Skin Treatment category," stated Jona Mancuso, Marketing Director at Carma Laboratories, Inc. "We are in excellent company and feel that this is a major milestone for the Carmex brand."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes